A randomized, placebo-controlled trial of bronchodilators for bronchoscopy in patients with COPD

Chest

Volumn 131, Issue 3, 2007, Pages 765-772

  Stolz, Daiana ^a,b   Pollak, Vincent ^a   Chhajed, Prashant N ^a   Gysin, Christian ^a   Pflimlin, Eric ^a   Tamm, Michael ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Bronchoscopy; COPD; Premedication

Indexed keywords

ATROPINE; BENZODIAZEPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYDROCODONE; IPRATROPIUM BROMIDE; LIDOCAINE; MIDAZOLAM; OPIATE; PLACEBO; SALBUTAMOL; SEDATIVE AGENT; SHORT ACTING DRUG; STEROID;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; FORCED EXPIRATORY VOLUME; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY;

EID: 33947408141     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2308     Document Type: Article

References (36)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349:1498-1504
2. British Thoracic Society guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52(suppl):S1-28
3. National Heart, Lung, and Blood Institute. Morbidity and mortality: 2002 chartbook on cardiovascular, lung and blood diseases. Bethesda, MA: National Institutes of Health, 2002
4. Pue CA, Pacht ER. Complications of fiberoptic bronchoscopy at a university hospital. Chest 1995; 107:430-432
5. Joos L, Patuto N, Chhajed PN, et al. Diagnostic yield of flexible bronchoscopy in current clinical practice. Swiss Med Wkly 2006; 136:155-159
6. Saad CP, Murthy S, Krizmanich G, et al. Self-expandable metallic airway stents and flexible bronchoscopy: long-term outcomes analysis. Chest 2003; 124:1993-1999
7. Maxfield RA. New and emerging minimally invasive techniques for lung volume reduction. Chest 2004; 125:777-783
8. Busse WW, Wanner A, Adams K, et al. Investigative bronchoprovocation and bronchoscopy in airway diseases. Am J Respir Crit Care Med 2005; 172:807-816
9. Mavritsin LE, Lifshits NA. Complications in the fiber bronchoscopy of bronchial asthma patients [in Russian]. Klin Med (Mosk) 1980; 58:37-40
10. Fish JE, Peterman VI. Effects of inhaled lidocaine on airway function in asthmatic subjects. Respiration 1979; 37:201-207
11. Djukanovic R, Wilson JW, Lai CK, et al. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis 1991; 143: 772-777
12. Van Vyve T, Chanez P, Bousquet J, et al. Safety of bronchoalveolar lavage and bronchial biopsies in patients with asthma of variable severity. Am Rev Respir Dis 1992; 146:116-121
13. Rankin JA, Snyder PE, Schachter EN, et al. Bronchoalveolar lavage: its safety in subjects with mild asthma. Chest 1984; 85:723-728
14. British Thoracic Society guidelines on diagnostic flexible bronchoscopy, Thorax 2001; 56(suppl):i1-i21
15. Jarjour NN, Peters SP, Djukanovic R, et al. Investigative use of bronchoscopy in asthma. Am J Respir Crit Care Med 1998; 157:692-697
16. Hattotuwa K, Gamble EA, O'Shaughnessy T, et al. Safety of bronchoscopy, biopsy, and BAL in research patients with COPD. Chest 2002; 122:1909-1912
17. Workshop summary and guidelines: investigative use of bronchoscopy, lavage and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol 1991; 88:808-814
18. Wood-Baker R, Burdon J, McGregor A, et al. Fibre-optic bronchoscopy in adults: a position paper of the Thoracic Society of Australia and New Zealand. Intern Med J 2001; 31:479-487
19. Global Initiative for Chronic Obstructive Lung Disease. Pocket guide to COPD diagnosis, management, and prevention: a guide for health care professionals, 2005. Available at: http://www.goldcopd.org/. Accessed November 1, 2006
20. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
21. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel; official position of the European Respiratory Society [in French]. Rev Mal Respir 1994; 11(Suppl3):5-40
22. Chhajed PN, Glanville AR. Management of hypoxemia during flexible bronchoscopy. Clin Chest Med 2003; 24:511-516
23. Stolz D, Chhajed PN, Leuppi J, et al. Nebulized lidocaine for flexible bronchoscopy: a randomized, double-blind, placebo-controlled trial. Chest 2005; 128:1756-1760
24. Stolz D, Chhajed PN, Leuppi JD, et al. Cough suppression during flexible bronchoscopy using combined sedation with midazolam and hydrocodone: a randomised, double blind, placebo controlled trial. Thorax 2004; 59:773-776
25. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-338
26. Spanevello A, Migliori GB, Satta A, et al. Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics. Respir Med 1998; 92:191-197
27. Humbert M, Robinson DS, Assoufi B, et al. Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks. Thorax 1996; 51:664-669
28. Jarjour NN, Calhoun WJ. Bronchoalveolar lavage in stable asthmatics does not cause pulmonary inflammation. Am Rev Respir Dis 1990; 142:100-103
29. Belen J, Neuhaus A, Markowitz D, et al. Modification of the effect of fiberoptic bronchoscopy on pulmonary mechanics. Chest 1981; 79:516-519
30. Inoue H, Aizawa H, Takata S, et al. Ipratropium bromide protects against bronchoconstriction during bronchoscopy. Lung 1994; 172:293-298
31. Neuhaus A, Markowitz D, Rotman HH, et al. The effects of fiberoptic bronchoscopy with and without atropine premedication on pulmonary function in humans. Ann Thorac Surg 1978; 25:393-398
32. Zavala DC, Godsey K, Bedell GN. The response to atropine sulfate given by aerosol and intramuscular routes to patients undergoing fiberoptic bronchoscopy. Chest 1981; 79:512-515
33. Salisbury BG, Metzger LF, Altose MD, et al. Effect of fiberoptic bronchoscopy on respiratory performance in patients with chronic airways obstruction. Thorax 1975; 30:441-446
34. Greig JH, Cooper SM, Kasimbazi HJ, et al. Sedation for fibre optic bronchoscopy. Respir Med 1995; 89:53-56
35. Bright E, Roseveare C, Dalgleish D, et al. Patient-controlled sedation for colonoscopy: a randomized trial comparing patient-controlled administration of propofol and alfentanil with physician-administered midazolam and pethidine. Endoscopy 2003; 35:683-687
36. Webb AR, Doherty JF, Chester MR, et al. Sedation for fibreoptic bronchoscopy: comparison of alfentanil with papaveretum and diazepam. Respir Med 1989; 83:213-217